Artrya Limited (ASX:AYA)
Australia
· Delayed Price · Currency is AUD 3.020
-0.380 (-11.18%)
At close: Mar 9, 2026
Artrya Market Cap
Artrya has a market cap or net worth of 477.41 million as of March 9, 2026. Its market cap has increased by 513.27% in one year.
Market Cap
477.41M
Enterprise Value
401.20M
Revenue
29.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.02
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 477.41M, an increase of 300.78%. That is a compound annual growth rate of 38.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 537.49M | -27.81% |
| Dec 31, 2025 | 744.58M | 1,435.71% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Echo IQ | 478.45M |
| Cogstate | 376.57M |
| Alcidion Group | 134.30M |
| BlinkLab | 98.21M |
| Singular Health Group | 74.19M |
| Mach7 Technologies | 74.03M |
| PharmX Technologies | 72.54M |
| Beamtree Holdings | 47.96M |